Company news

Eckert & Ziegler SE news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Eckert & Ziegler: Adjusted EBIT +25% in the Third Quarter. 2026 Forecast Confirmed

November 12, 2026

Eckert & Ziegler Receives GMP Certificate for Actinium-225

October 28, 2026

Eckert & Ziegler and TerThera Sign Supply Agreement to Bring Next-Generation GMP Terbium-161 Radiopharmaceutical Therapies to Brazilian Patient

October 13, 2026

Eckert & Ziegler Remains on Track in the First Half of 2026

August 13, 2026

Eckert & Ziegler: Annual General Meeting Approves Significantly Higher...

June 24, 2026

Eckert & Ziegler and DC Pharma Open Commercial Medical Isotope Production Site in Jintan

June 11, 2026

Eckert & Ziegler Enters Partnership with Thor Medical to Enable Access of Lead-212 for the Pharmaceutical Industry

May 28, 2026

Eckert & Ziegler Receives “Best Managed Companies Award” Once Again

May 22, 2026

Invitation and Agenda AGM Eckert & Ziegler 2026 (Invitation and Agenda AGM Eckert Ziegler 2026)

May 13, 2026

Proposal on the appropriation of net income Eckert & Ziegler for the FY 2025 (Proposal on the appropriation of net income 2025)

May 13, 2026

Report of the Supervisory Board FY 2025 (Report of the Supervisory Board)

May 13, 2026

Report of the Management Board to the Annual General Meeting pursuant to Sections 203(2), second sentence, and 186(4), second sentence, of the German Stock Corporation Act (AktG) (Report of the Executive Board to the Annual General Meeting Item 9 2025)

May 13, 2026

Remuneration System Executive Board 2025 (Remuneration System Executive Board)

May 13, 2026

Quarterly Report I / 2026

May 12, 2026

Eckert & Ziegler Secures Patient Access to Critical Eye Cancer Treatment with MDR Certification for Ru-106 Eye Applicators

April 10, 2026

Presentation FY 2025 (26/03/2026)

March 26, 2026

Eckert & Ziegler SE: Dr. Gunnar Mann, Allocation of 12,545 shares as part of executive board remuneration (own shares of the issuer). This is a share-based remuneration with an automatic...

March 24, 2026

Eckert & Ziegler SE: Dr. Harald Hasselmann, Allocation of 62,541 shares as part of executive board remuneration (own shares of the issuer). This is a share-based remuneration with an...

March 24, 2026

Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025

March 6, 2026

Eckert & Ziegler SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

February 24, 2026

Eckert & Ziegler and UJF Significantly Increase Production Volume for Actinium-225

February 16, 2026

Declaration on Compliance 2025 (Erklarung zur Unternehmensfuhrung und Corporate Governance Bericht 2025 engl)

January 30, 2026

Eckert & Ziegler on Track as Planned and Achieves Another Record Year in 2025

January 29, 2026

Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026

Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50

June 18, 2025

Decks

The 5 newest of 14 decks. Every deck is listed under its year.